Latest filing published 25 Feb 2015 for Rocket Pharmaceuticals, INC..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +13.3%Entry US$24.08 · Close at T+365 US$27.28
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Care Capital II LLC: trading record in brief
Care Capital II LLC discloses dealings in 3 companies, chiefly Acura Pharmaceuticals, Inc, Vanda Pharmaceuticals Inc. and Rocket Pharmaceuticals, Inc. Between 18 April 2006 and 23 February 2015, the trades on record add up to 107 filings.
Both buying and selling appear: 4 purchases worth €3.2M, against 96 sales worth €40.4M. The totals exclude 3 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2015, the count stands at 1 purchase and no sales.
The record was last updated on 25 February 2015 with a transaction in Rocket Pharmaceuticals, Inc. The most recent open-market purchase was published on 25 February 2015, 4,274 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Care Capital II LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,394,645 sharesCommon StockSEC:0001209191-15-018755:0
- 63,560 sharesCommon StockSEC:0001209191-15-018755:1
- 603,832 shares@ US$6.00Common StockSEC:0001209191-15-018755:2Canonical exit: 24 May 2015 (T+90)
- 179,968 shares@ US$2.04Common StockSEC:0001104659-14-015385:0
- 51,204 shares@ US$2.04Common StockSEC:0001104659-14-015385:1
- 20,032 shares@ US$2.04Common StockSEC:0001104659-14-013647:0
- 5,400 shares@ US$2.02Common StockSEC:0001104659-13-075709:0
- 31,610 shares@ US$2.04Common StockSEC:0001104659-13-054956:0
- 14,200 shares@ US$2.00Common StockSEC:0001104659-13-053536:0
- 500,000 shares@ US$2.36Common StockSEC:0001104659-13-053194:0
- 81,082 shares@ US$2.04Common StockSEC:0001104659-13-053194:1
- 39,239 shares@ US$2.01Common StockSEC:0001104659-13-052010:0
- 28,000 shares@ US$2.02Common StockSEC:0001104659-13-052010:1
- 9,042 shares@ US$2.01Common StockSEC:0001104659-13-052010:2
- 36,000 shares@ US$2.02Common StockSEC:0001104659-13-051122:0
- 24,000 shares@ US$2.03Common StockSEC:0001104659-13-051122:1
- 23,000 shares@ US$2.03Common StockSEC:0001104659-13-051122:2
- 40,000 shares@ US$2.15Common StockSEC:0001104659-13-050228:0
- 32,000 shares@ US$2.13Common StockSEC:0001104659-13-050228:1
- 42,000 shares@ US$2.08Common StockSEC:0001104659-13-050228:2
- 32,000 shares@ US$2.18Common StockSEC:0001104659-13-049473:0
- 28,000 shares@ US$2.15Common StockSEC:0001104659-13-049473:1
- 30,000 shares@ US$2.15Common StockSEC:0001104659-13-049473:2
- 45,000 shares@ US$2.19Common StockSEC:0001104659-13-048410:0
- 35,000 shares@ US$2.20Common StockSEC:0001104659-13-048410:1
25 of 102 declarations
